Private Capital Group, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,000
-33.3%
550.0%0.00%
+100.0%
Q1 2022$3,000
-25.0%
55
-23.6%
0.00%0.0%
Q4 2021$4,0000.0%72
+12.5%
0.00%0.0%
Q3 2021$4,000
-20.0%
64
-42.9%
0.00%0.0%
Q2 2021$5,000
+150.0%
112
+93.1%
0.00%
Q1 2021$2,000
+100.0%
58
+480.0%
0.00%
Q4 2020$1,000
-83.3%
10
-92.0%
0.00%
-100.0%
Q2 2020$6,000
-14.3%
125
-20.9%
0.00%
-50.0%
Q1 2020$7,0001580.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders